ArticleJournal of geriatric oncology2026
Differential effects of social determinants on cancer survival by age at diagnosis: A population-based study in Alabama.
Article in Journal of geriatric oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
introductionSocial determinants of health (SDOH) are known to influence cancer outcomes. It is unknown whether SDOH effects on cancer survival differ by age at diagnosis or whether known differences in survival by race are consistent across age groups. Since the U.S. population is aging and becoming increasingly racially diverse, it is important to understand how SDOH at both neighborhood and individual levels impact survival in cancer survivors across age groups at diagnosis. MATERIALS AND
methodsThis retrospective, population-based study utilized data from the Alabama Statewide Cancer Registry of adults (≥18 years) diagnosed with incident breast, prostate, colorectal (CRC), or lung cancers between 2010 and 2019. We included exposures of social vulnerability index (SVI), rural-urban residency, and insurance status at diagnosis. We evaluated an outcome of overall survival (OS) in months from date of diagnosis to date of death or end of follow-up. We estimated Cox proportional hazards regression models stratified by cancer type adjusting for demographics and clinical characteristics. We conducted additional models stratified by age group at diagnosis (≥65 vs. <65 years) and additionally age-race groups.
resultsThe sample included 26,031 incident breast, 24,567 prostate, 18,821 CRC, and 27,319 lung cancer cases. Across all cancer types, higher SVI was associated with higher risk of death with consistency across age groups. Being insured by Medicare/public insurance was associated with higher risk of death, but effects were higher among those diagnosed <65 and those identifying as White. DISCUSSION: Higher levels of SVI and being insured by Medicare or public insurance are associated with worse survival among adults with breast, prostate, CRC, and lung cancer in Alabama with stronger effects observed among those diagnosed under <65. These results indicate that age at diagnosis is important in contextualizing and understanding differences in survival. Future efforts to improve disparities in mortality among cancer survivors should target interventions to those experiencing social vulnerability and younger at diagnosis. However, given that older adults experience differential care needs, social interventions may improve more proximal drivers of mortality in older adults with cancer such as frailty, but this needs further study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.